Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 02, 2018

SELL
$12.65 - $18.85 $126,500 - $188,500
-10,000 Closed
0 $0
Q4 2017

Feb 12, 2018

SELL
$17.45 - $25.6 $87,250 - $128,000
-5,000 Reduced 33.33%
10,000 $179,000
Q3 2017

Nov 02, 2017

BUY
$18.9 - $28.2 $283,500 - $423,000
15,000
15,000 $377,000

Others Institutions Holding PRTK

About Paratek Pharmaceuticals, Inc.


  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Harvest Management LLC Portfolio

Follow Harvest Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Management LLC with notifications on news.